Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.040
-0.030 (-2.80%)
Nov 20, 2024, 4:00 PM EST - Market closed
Co-Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 0.68 | 0.99 | 34.22 | 97.89 | 74.55 | 0.21 | Upgrade
|
| Other Revenue | 6.65 | 5.82 | - | - | - | - | Upgrade
|
| Revenue | 7.32 | 6.81 | 34.22 | 97.89 | 74.55 | 0.21 | Upgrade
|
| Revenue Growth (YoY) | 57.16% | -80.09% | -65.04% | 31.30% | 34579.90% | 438.63% | Upgrade
|
| Cost of Revenue | 3.71 | 4.18 | 5.48 | 11.57 | 16.59 | 0.11 | Upgrade
|
| Gross Profit | 3.61 | 2.63 | 28.74 | 86.31 | 57.96 | 0.1 | Upgrade
|
| Selling, General & Admin | 19.92 | 21.14 | 21.61 | 24.95 | 12.94 | 4.56 | Upgrade
|
| Research & Development | 22.35 | 22.96 | 17.44 | 14.96 | 3.19 | 1.37 | Upgrade
|
| Operating Expenses | 43.61 | 45.33 | 40.33 | 40.25 | 16.27 | 6 | Upgrade
|
| Operating Income | -40 | -42.71 | -11.59 | 46.06 | 41.69 | -5.89 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.11 | Upgrade
|
| Interest & Investment Income | 1.41 | 1.16 | 0.7 | 0.05 | 0.1 | 0.04 | Upgrade
|
| Earnings From Equity Investments | -0.14 | 0.1 | -0.33 | -0.43 | 0.78 | -0.23 | Upgrade
|
| EBT Excluding Unusual Items | -38.72 | -41.44 | -11.22 | 45.68 | 42.57 | -6.2 | Upgrade
|
| Impairment of Goodwill | - | - | -15.39 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.58 | 2.24 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | -0 | -0.14 | -0.04 | -0 | 0 | Upgrade
|
| Other Unusual Items | -0.25 | 1.09 | 7.9 | - | - | - | Upgrade
|
| Pretax Income | -37.38 | -38.11 | -18.85 | 45.64 | 42.57 | -6.2 | Upgrade
|
| Income Tax Expense | 3.9 | -2.78 | -4.61 | 8.98 | 0.09 | - | Upgrade
|
| Net Income | -41.28 | -35.33 | -14.24 | 36.66 | 42.48 | -6.2 | Upgrade
|
| Net Income to Common | -41.28 | -35.33 | -14.24 | 36.66 | 42.48 | -6.2 | Upgrade
|
| Net Income Growth | - | - | - | -13.70% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 30 | 29 | 31 | 29 | 27 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 29 | 31 | 30 | 28 | 17 | Upgrade
|
| Shares Change (YoY) | 2.06% | -6.77% | 5.27% | 6.80% | 67.10% | 34.22% | Upgrade
|
| EPS (Basic) | -1.38 | -1.20 | -0.45 | 1.27 | 1.59 | -0.37 | Upgrade
|
| EPS (Diluted) | -1.38 | -1.20 | -0.45 | 1.23 | 1.52 | -0.37 | Upgrade
|
| EPS Growth | - | - | - | -19.08% | - | - | Upgrade
|
| Free Cash Flow | -26.84 | -23.45 | 5.14 | 40.41 | 27.39 | -5.64 | Upgrade
|
| Free Cash Flow Per Share | -0.90 | -0.80 | 0.16 | 1.35 | 0.98 | -0.34 | Upgrade
|
| Gross Margin | 49.30% | 38.57% | 83.98% | 88.17% | 77.75% | 47.70% | Upgrade
|
| Operating Margin | -546.37% | -626.92% | -33.87% | 47.06% | 55.93% | -2741.61% | Upgrade
|
| Profit Margin | -563.91% | -518.68% | -41.61% | 37.45% | 56.98% | -2882.00% | Upgrade
|
| Free Cash Flow Margin | -366.65% | -344.20% | 15.02% | 41.28% | 36.74% | -2622.80% | Upgrade
|
| EBITDA | -38.67 | -41.48 | -10.31 | 46.4 | 41.83 | -5.83 | Upgrade
|
| EBITDA Margin | - | - | -30.13% | 47.40% | 56.11% | - | Upgrade
|
| D&A For EBITDA | 1.33 | 1.23 | 1.28 | 0.34 | 0.14 | 0.07 | Upgrade
|
| EBIT | -40 | -42.71 | -11.59 | 46.06 | 41.69 | -5.89 | Upgrade
|
| EBIT Margin | - | - | -33.87% | 47.06% | 55.93% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 19.67% | 0.21% | - | Upgrade
|
| Revenue as Reported | 7.32 | 6.81 | 34.22 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.